Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Nov 26, 2020; 8(22): 5564-5575
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5564
Table 1 Inclusion and exclusion criteria
Inclusion criteriaExclusion criteria
Radiologic confirmation of locally advanced pancreatic cancerResectable pancreatic adenocarcinoma
Histological or cytological confirmation of pancreatic adenocarcinomaChemotherapy or radiotherapy prior to the procedure
Tumor diameter ≤ 5 cmAllergy to contrast media
Age ≥ 18 yrHistory of epilepsy
Adequate bone marrow, liver, renal, and coagulation function: Hemoglobin level ≥ 115 g/L; platelet count ≥ 100 × 109/L; neutrophil count ≥ 2 × 109/L; white blood cell count ≥ 4 × 109/LHistory of cardiac disease: Congestive heart failure > NYHA classification 2; cardiac arrhythmias requiring anti-arrhythmic therapy or pacemaker
PS 0-2Uncontrolled hypertension
Written informed consentAny implanted metal stent/device within the area of ablation that cannot be removed